Aimee  Wilkin  to  HIV Protease Inhibitors
                            
                            
                                This is a "connection" page, showing publications  Aimee  Wilkin  has written about  HIV Protease Inhibitors.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.019
         
        
        
     
 
    
        
        - 
            Molina JM, Podsadecki TJ, Johnson MA, Wilkin A, Domingo P, Myers R, Hairrell JM, Rode RA, King MS, Hanna GJ. A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks. AIDS Res Hum Retroviruses. 2007 Dec; 23(12):1505-14.
            
            
                Score: 0.019